CD8A and COVID-19: While circulating SARS-CoV-2 S-targeted and non-S-targeted CD4+ cells were identified in 100% of COVID-19 convalescents, SARS-CoV-2-specific CD8+ T cell responses were only observed in 70% of COVID-19 convalescent patients.